Module 19: Evaluation & Use of Clinical Information to Improve Patient Care - 2010*

Program Description


Content Expert

H. E. Davidson, PharmDEditor-in-Chief, The Consultant Pharmacist&PartnerInsight Therapeutics, LLC



H. E. Davidson, PharmD, has no relevant financial relationship to disclose.


Course Objectives

19.01 Evidence-Based Medicine and Clinical Studies

  • Define the concept of evidence-based medicine
  • Explain how levels of evidence are classified
  • Differentiate Type I and Type II errors of statistical interpretation
  • Explain the significance of the p value and confidence intervals in interpreting clinical studies
  • Describe measures of disease frequency and the use of risk and odds ratios in epidemiological studies
  • Differentiate prospective and retrospective study designs in terms of their statistical effectiveness, advantages and limitations
  • Cite examples of prospective and retrospective study designs
  • Differentiate the features of parallel and crossover randomized controlled trials Describe the uses and principal features of multi-center study designs and meta-analyses
  • Describe study designs commonly used in epidemiological studies and provide examples of each
  • Define measures of disease frequency and effect commonly used in epidemiological studies

19.02 Evaluating Clinical Studies

  • Define the concept of validity, and describe its significance in evaluating the quality of clinical research
  • Differentiate between internal validity and external validity
  • Explain how the title, abstract, and introduction for a given research study can help evaluate the quality of the information presented
  • Cite criteria for evaluating the quality of the methods, results, discussion and conclusions described in a given research study
  • List questions to ask when evaluating the quality of a review article

19.03 Use of Practice Guidelines

  • Trace the historical development of practice guidelines, including key legislation and organizations involved
  • Describe the principal intent of practice guidelines
  • Describe how practice guidelines are developed
  • Explain why practice guidelines are not universally implemented
  • Outline proposed recommendations to making geriatric practice guidelines more readily available to clinicians
  • List sources of practice guidelines
  • Describe the limitations of practice guidelines, based on the method in which they were developed

19.04 Medical Use Evaluations

  • Explain the purpose of medical use evaluations
  • Explain the processes within the medication use system
  • Describe the principal approach used to conduct medication use evaluations
  • Identify criteria and related clinical indicators for the selection of drugs to be studied medication use evaluations
  • Compare and contrast prospective, concurrent, and retrospective medication use evaluations
  • Describe different ways in which the geriatric pharmacist can participate inmedical use evaluations
  • List the kinds of data that are typically collected during a medical use evaluation
  • Describe the typical structure of a medication use evaluation report
  • List resources available to the geriatric pharmacist for the selection of criteria for medication use evaluations

Each user has 365 days access to the course from date of purchase.

Credit Statement

 Continuing Pharmacy Education: The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This knowledge-based activity (UAN: 0203-0000-10-097-H04-P) was developed by ASCP and is approved for 1.0 Contact Hour.

This course is not approved for Florida consultant license requirements.



Course details

  • ACPE: 1.00
  • Course opens: Thu, 07/01/2010 - 00:00
  • Course expires: Mon, 07/01/2013 - 00:00
  • Non-member Cost: $15.00
  • Member Cost: $10.00

This course closed on July, 1st 2013 and is no longer available for enrollments.